ZBiotics raised $12M in a Series A funding round led by Spring Tide Capital to expand retail operations and further research in genetically engineered probiotics.

Aug 27, 2024•over 1 year ago

Amount Raised

$12 Million

Round Type

series a

San FranciscoBiotechnologyHealth Care

Investors

Seaside VenturesGoat Rodeo CapitalSeamless CapitalAccess CapitalSpring Tide Capital

Description

ZBiotics has closed a $12M Series A funding round, which will support its growth in consumer demand and product development. The round was led by Spring Tide Capital and included participation from several other investors.

Company Information

Company

ZBiotics

Location

San Francisco, California, United States

About

ZBiotics is the world's first maker of genetically engineered probiotics, purpose-built to improve our health by addressing modern biological challenges. Founded by a team of Ph.D. scientists, the company creates genetically engineered probiotics for specific use cases. Their flagship product, the Pre-Alcohol Probiotic Drink, mimics liver function to break down alcohol toxins. ZBiotics is committed to transparency and offers sustainable, effective solutions through modern biotechnology.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends